Post by Rebrain.

2,750 followers

๐—ง๐—ต๐—ฎ๐˜โ€™๐˜€ ๐—ฎ ๐˜„๐—ฟ๐—ฎ๐—ฝ ๐—ผ๐—ป ๐—”๐—ฆ๐—ฆ๐—™๐—ก ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฒ. A few busy days filled with great conversations, inspiring sessions, booth visits, coffee runs and lots of discussions around the future of brain targeting. From clinicians and researchers to long-time partners and new connections, it was great to see so many people stopping by Booth 116 to exchange with the Rebrain team. One thing clearly stood out throughout the congress: the growing interest in more precise, reproducible and patient-centered targeting approaches. Weโ€™re leaving Cleveland energized, inspired and more motivated than ever to keep advancing clinically validated and patient-centered targeting solutions. Huge thanks to everyone who stopped by the booth, shared ideas or just came to say hi. Ausaf Bari, Jean-Philippe Langevin, Charles Munyon, sepehr sani, Rees Cosgrove, Vibhor Krishna, Daniel Cleary, Dustin Papon, David Caumartin, Nejib Zemzemi, Matt Turner, Robert Law, MBA, Lilou Marchand #ASSFN2026 #FunctionalNeurosurgery #Neurosurgery

Post contentPost contentPost contentPost contentPost contentPost contentPost content